Abbott Laboratories  

(Public, NYSE:ABT)   Watch this stock  
Find more results for Heather Allen
36.31
-0.90 (-2.42%)
Feb 11 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 36.02 - 36.85
52 week 36.00 - 51.74
Open 36.44
Vol / Avg. 7.72M/8.60M
Mkt cap 54.47B
P/E 20.97
Div/yield 0.26/2.86
EPS 1.73
Shares 1.49B
Beta 1.02
Inst. own 71%
Apr 22, 2016
Abbott Laboratories Annual Shareholders Meeting (Estimated) - 10:00AM EDT - Add to calendar
Apr 20, 2016
Q1 2016 Abbott Laboratories Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Feb 11, 2016
Abbott Laboratories at Leerink Partners Global Healthcare Conference
Jan 28, 2016
Q4 2015 Abbott Laboratories Earnings Release
Jan 28, 2016
Q4 2015 Abbott Laboratories Earnings Call - Webcast
Jan 11, 2016
Abbott Laboratories at JPMorgan Healthcare Conference - Webcast
Nov 18, 2015
Abbott Laboratories at Jefferies Autumn Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 13.40% 12.77%
Operating margin 15.59% 15.46%
EBITD margin - 18.75%
Return on average assets - -
Return on average equity - -
Employees 77,000 -
CDP Score - 93 B

Address

100 Abbott Park Rd
ABBOTT PARK, IL 60064-3500
United States - Map
+1-847-9376100 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a range of health care products. Abbott operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products.

Officers and directors

Miles D. White Chairman of the Board, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brian B. Yoor Chief Financial Officer, Senior Vice President - Finance
Bio & Compensation  - Reuters
Thomas C. Freyman Executive Vice President - Finance and Administration
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Hubert L. Allen Executive Vice President, General Counsel, Secretary
Age: 50
Bio & Compensation  - Reuters
Stephen R. Fussell Executive Vice President - Human Resources
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Richard W. Ashley Executive Vice President - Corporate Development
Age: 71
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brian J. Blaser Executive Vice President - Diagnostics Products
Age: 50
Bio & Compensation  - Reuters
John M. Capek Ph.D. Executive Vice President - Ventures
Age: 53
Bio & Compensation  - Reuters
Heather L. Mason Executive Vice President - Nutritional Products, Global Commercial Operations.
Age: 54
Bio & Compensation  - Reuters
Michael J. Warmuth Executive Vice President - Established Pharmaceuticals
Age: 52
Bio & Compensation  - Reuters